Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study in acute cerebral infarction
RB Bauer, H Tellez - Stroke, 1973 - Am Heart Assoc
RB Bauer, H Tellez
Stroke, 1973•Am Heart AssocFifty-four patients with acute cerebral infarction were included in a double-blind study to
evaluate Decadron® as therapy. When comparison of patients with similar levels of
consciousness was made, there was no significant difference between those patients
receiving Decadron® and those receiving placebo therapy. Three patients developed
gastrointestinal tract bleeding in the placebo group, but there were none in the Decadron®-
treated group. There was no good correlation between the clinical state of the patient and …
evaluate Decadron® as therapy. When comparison of patients with similar levels of
consciousness was made, there was no significant difference between those patients
receiving Decadron® and those receiving placebo therapy. Three patients developed
gastrointestinal tract bleeding in the placebo group, but there were none in the Decadron®-
treated group. There was no good correlation between the clinical state of the patient and …
Fifty-four patients with acute cerebral infarction were included in a double-blind study to evaluate Decadron® as therapy. When comparison of patients with similar levels of consciousness was made, there was no significant difference between those patients receiving Decadron® and those receiving placebo therapy.
Three patients developed gastrointestinal tract bleeding in the placebo group, but there were none in the Decadron®-treated group.
There was no good correlation between the clinical state of the patient and the CSF pressure, either on admission or during the 14-day course of the study.
Am Heart Assoc